Theravance Biopharma, Inc.·4

Nov 13, 8:42 PM ET

Farnum Rhonda 4

4 · Theravance Biopharma, Inc. · Filed Nov 13, 2024

Insider Transaction Report

Form 4
Period: 2024-11-11
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Transactions
  • Sale

    Ordinary Shares

    2024-11-11$9.00/sh4,000$36,000322,743 total

Documents

1 file
  • 4
    form4-11142024_011103.xmlPrimary